Copyright
©The Author(s) 2017.
World J Gastroenterol. Jun 21, 2017; 23(23): 4285-4292
Published online Jun 21, 2017. doi: 10.3748/wjg.v23.i23.4285
Published online Jun 21, 2017. doi: 10.3748/wjg.v23.i23.4285
Table 1 Patients’ characteristics n (%)
Patients (n = 49) | |
Age yr (mean; extreme) | 33; 14-70 |
Sex ratio (men/women) | 0.58 |
Familial history of IBD | 4 (8.2) |
Smoking | 21 (42.9) |
Mean duration of CD (mo) | 72 (0-300) |
Location | |
L1 ileal | 4 (8.2) |
L2 colonic | 15 (30.6) |
L3 ileocolonic | 22 (44.9) |
L2 or L3 + L4 upper disease | 8 (16.3) |
Disease behavior | |
Inflammatory | 34 (69.4) |
Structuring | 8 (16.3) |
Penetrating | 7 (14.3) |
Extraintestinal manifestations | 11 (22.4) |
Ileocolonic resection | 11 (22.4) |
Previous perianal surgery | 40 (81.6) |
CRP (mg/L) | 11.5 (1.6-167) |
Albumin rate (g/L) | 35.2 (20-49.2) |
- Citation: Thomassin L, Armengol-Debeir L, Charpentier C, Bridoux V, Koning E, Savoye G, Savoye-Collet C. Magnetic resonance imaging may predict deep remission in patients with perianal fistulizing Crohn's disease. World J Gastroenterol 2017; 23(23): 4285-4292
- URL: https://www.wjgnet.com/1007-9327/full/v23/i23/4285.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i23.4285